Drug application
UNIPEN (NAFCILLIN SODIUM)
Drugs@FDA NDA 050199 · WYETH AYERST
Key facts
| Drug name | UNIPEN |
|---|---|
| Active ingredients | NAFCILLIN SODIUM |
| Application type | NDA |
| Application number | 050199 |
| Company | WYETH AYERST |
| Dosage forms | FOR SOLUTION, ORAL |
| Strength | EQ 250MG BASE/5ML |
| Marketing status | Discontinued |
| Reference listed drug | No |
| Latest submission status date | Oct 11, 1965 |
At a glance
- 1–9 Submissions
- 10–99 Supplements
- None Label versions
- 1–9 Products
- None Therapeutic equivalents
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Drugs@FDA applications
Drugs@FDA covers FDA-approved brand-name and generic drugs and therapeutic biologics, with their applications (NDA, ANDA or BLA), products, submissions and labels.